Blogs » Health » Global Metabolomics Market 2023 | Trends, Size & Forecast 2023

Global Metabolomics Market 2023 | Trends, Size & Forecast 2023

  • IMARC Group, a leading market research company, has recently releases report titled, “ Metabolomics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028 ” The study provides a detailed analysis of the industry, including the global metabolomics market size, share, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advances in the market.

    Report Highlights

    How big is the metabolomics market?

    The global metabolomics market size reached US$ 2.4 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 4.7 Billion by 2028, exhibiting a growth rate (CAGR) of 11.55% during 2023-2028.

    What is metabolomics?

    The study and examination of tiny molecules found in cells, biofluids, tissues, and living things is known as metabolomics.It involves a number of procedures, including data mining, extraction, and analysis, as well as the acquisition, separation, and detection of analytes.It uses a variety of analytical methods, including high-resolution mass spectrometry (HRMS) and nuclear magnetic resonance (NMR) spectroscopy. It serves as an effective tool in the diagnosis of a disease and facilitates the prediction of treatment response and survival. As it is also employed to detect the recurrence of a disease after therapy, metabolomics is gaining traction in biomarker and drug discovery, toxicology, nutrigenomics, and personalized medicines across the globe.

    Request Free Sample Report (Exclusive Offer on this report):

    What are the growth prospects and trends in the metabolomics industry?

    One of the primary factors favourably affecting the market at the moment is the growing worldwide elderly population as well as the rising prevalence of cancer and various cardiovascular and neurological ailments.Additionally, the demand for untargeted metabolomics for IEM screening is being sparked by an increase in the incidence of inborn errors of metabolism (IEM), such as fructose intolerance, maple syrup urine disease (MSUD), fatty acid oxidation abnormalities, mitochondrial disorders, and phenylketonuria (PKU). In line with this, increasing investments in research and development (R&D) activities and rising integration of machine learning (ML) algorithms with metabolomics to identify weight gain biomarkers is fueling the growth of the market.

    What is included in market segmentation?

    The report has segmented the market into the following categories:

    Insights on Market Segmentation:

    Market Breakup by Product:

    • Metabolomics Instruments
    • Metabolomics Bioinformatics Tools and Services

    Market Breakup by Indication:

    • Cancer
    • Cardiovascular Disorders
    • Neurological Disorders
    • Inborn errors of metabolism
    • Others

    Market Breakup by Application:

    • Biomarkers and Drug Discovery
    • toxicology
    • Nutrigenomics
    • Personalized Medicines
    • Others

    Market Segmentation by Region:

    • North America
    • Asia-Pacific
    • Europe
    • United Kingdom
    • Latin America
    • Middle East and Africa

    Who are the key players operating in the industry?

    The report covers the major market players including:

    • Agilent Technologies, Inc.
    • Biocrates Life Sciences AG
    • Bio-Rad Laboratories, Inc. (BIO)
    • Bruker Corporation (BRKR)
    • Danaher Corporation (DHR)
    • Metabolon Inc.
    • Thermo Fisher Scientific Inc.
    • Waters Corporation, etc.

    Ask Analyst for 10% Free Customized Report:

    If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

    About Us

    IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

    IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

    Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

    Contact us:

    IMARC Group
    USA: +1-631-791-1145 | Asia: +91-120-433-0800
    Address: 134 N 4th St. Brooklyn, NY 11249, USA
    Follow us on Twitter: @imarcglobal